Semaglutide is a GLP-1 receptor agonist extensively studied for its role in metabolic signaling and glucose regulation pathways. By mimicking incretin hormone activity, it has demonstrated strong relevance in research examining appetite signaling, insulin response mechanisms, and energy balance. Its robust clinical research background has contributed to growing scientific attention surrounding its metabolic pathway interactions. Investigators continue exploring how GLP-1 modulation influences weight-regulation models and systemic metabolic efficiency. With its expanding body of research, Semaglutide has become one of the most recognized peptides within modern metabolic science